Linezolid is active in vitro against quinupristin/dalfopristin resistant enterococci and staphylococci

被引：0

作者：

Siddiqui, F ^{[1
]}

Peterson, LR ^{[1
]}

Noskin, GA ^{[1
]}

机构：

[1] Northwestern Univ, Sch Med, Chicago, IL USA

来源：

CLINICAL INFECTIOUS DISEASES | 2001年 / 33卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

532

引用

页码：1179 / 1179

页数：1

共 50 条

[1] In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
Rybak, MJ
Hershberger, E
Moldovan, T
Grucz, RG
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) : 1062 - 1066
[2] In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
El-Azizi M.
Rao S.
Kanchanapoom T.
Khardori N.
[J]. Annals of Clinical Microbiology and Antimicrobials, 4 (1)
[3] Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci
von Eiff, C
Peters, G
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) : 569 - 573
[4] In vitro activity of tedizolid against linezolid-resistant staphylococci and enterococci
Silva-Del Toro, Stephanie L.
Greenwood-Quaintance, Kerryl E.
Patel, Robin
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 85 (01) : 102 - 104
[5] In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model
Allen, GP
Cha, R
Rybak, MJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2606 - 2612
[6] In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium
Jevitt, LA
Smith, AJ
Williams, PP
Raney, PM
McGowan, JE
Tenover, FC
[J]. MICROBIAL DRUG RESISTANCE, 2003, 9 (04) : 389 - 393
[7] In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium
Abb, Jochen
[J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 (03) : 358 - 360
[8] In vitro activity of linezolid & quinupristin/dalfopristin against Gram-positive cocci
Tünger, A
Aydemir, S
Uluer, S
Cilli, F
[J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2004, 120 (06) : 546 - 552
[9] Quinupristin/dalfopristin and linezolid have important roles in the treatment of infections due to vancomycin-resistant enterococci
不详
[J]. Drugs & Therapy Perspectives, 2002, 18 (9) : 14 - 17
[10] Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
Maraki, Sofia
Samonis, George
Dimopoulou, Dimitra
Mantadakis, Elpis
[J]. INFECTION AND CHEMOTHERAPY, 2014, 46 (04): : 253 - 256

← 1 2 3 4 5 →